These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 20489580)

  • 1. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy versus fortified antibiotics for bacterial keratitis.
    Rosenberg JB; Gritz DC
    Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V; Sharma N; Satpathy G; Titiyal J
    J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
    Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
    Moshirfar M; Mirzaian G; Feiz V; Kang PC
    J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Bashir H; Dave A; Mathur U
    Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoroquinolones in corneal ulcers.
    Galvis V; Tello A; Guerra AR; Acuña MF; Villarreal D
    Ophthalmology; 2013 Sep; 120(9):e61-2. PubMed ID: 24001539
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
    Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
    Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
    Gangopadhyay N; Daniell M; Weih L; Taylor HR
    Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
    Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
    Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
    Moshirfar M; Meyer JJ; Espandar L
    J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.